An aggressive and recurrent bilateral breast angiosarcoma in a young woman
Keywords:
Angiosarcoma, breast cancer, advanced breast cancer, cancer recurrence, breast angiosarcoma, sarcomasAbstract
Background and Purpose: Breast sarcoma is an uncommon kind of cancer that starts in the breast's connective tissues, which include the muscles, fat, blood vessels, and other tissues that support the breast. Breast sarcomas are not the same as more prevalent forms of breast cancer, which usually originate from glandular tissue (ducts or lobules). Breast sarcoma has several subtypes, one of which is angiosarcoma. It is characterized by aggression and originates from blood vessels. Less than 1% of all breast malignancies are breast angiosarcomas, making them extremely uncommon. When compared to other more prevalent types of breast cancer, it frequently affects younger women.
Methods: To better identify and distinguish breast angiosarcoma from other lesions, it is critical to assess and optimize currently available imaging modalities, such as mammography, ultrasound, and magnetic resonance imaging (MRI).
Results: Since angiosarcoma is an uncommon kind of cancer, there is a shortage of precise information on its course. Nonetheless, in comparison to more prevalent forms of breast cancer, angiosarcoma of the breast typically has a poorer prognosis. This is mostly because it is frequently detected at a later stage, and it may have a higher propensity to spread quickly to other body areas.
Conclusions: Breast angiosarcoma is a rare cancer that can be treated with surgery, radiation therapy, and chemotherapy. However, its aggressive nature may not always lead to effective treatment. The prognosis depends on factors like disease stage, tumor size, treatment response, and personal factors. Understanding angiosarcoma can help prevent misdiagnoses and prompt early medical attention. Medical professionals with extensive knowledge can offer specialized treatment and management approaches to patients with this rare cancer.
References
Terrier P, Terrier-Lacombe MJ, Mouriesse H, Friedman S, Spielmann M, Contesso G. Primary breast sarcoma: a review of 33 cases with immunohistochemistry and prognostic factors. Breast Cancer Res Treat. 1989;13(1):39-48. doi:10.1007/BF01806549
Arora TK, Terracina KP, Soong J, Idowu MO, Takabe K. Primary and secondary angiosarcoma of the breast. Gland Surg. 2014;3(1):28-34. doi:10.3978/j.issn.2227-684X.2013.12.03
Bentley H, Roberts J, Hayes M, et al. The Role of Imaging in the Diagnosis of Primary and Secondary Breast Angiosarcoma: Twenty-Five-Year Experience of a Provincial Cancer Institution. Clin Breast Cancer. 2023;23(2):e45-e53. doi:10.1016/j.clbc.2022.11.003
Wu WH, Ji QL, Li ZZ, Wang QN, Liu SY, Yu JF. Mammography and MRI manifestations of breast angiosarcoma. BMC Womens Health. 2019;19(1):73. Published 2019 Jun 10. doi:10.1186/s12905-019-0769-3
Scow JS, Reynolds CA, Degnim AC, Petersen IA, Jakub JW, Boughey JC. Primary and secondary angiosarcoma of the breast: the Mayo Clinic experience. J Surg Oncol. 2010;101(5):401-407. doi:10.1002/jso.21497
Gutkin PM, Ganjoo KN, Lohman M, et al. Angiosarcoma of the Breast: Management and Outcomes. Am J Clin Oncol. 2020;43(11):820-825. doi:10.1097/COC.0000000000000753
Kunkiel M, Maczkiewicz M, Jagiełło-Gruszfeld A, Nowecki Z. Primary angiosarcoma of the breast-series of 11 consecutive cases-a single-centre experience. Curr Oncol. 2018;25(1):e50-e53. doi:10.3747/co.25.3816
Dogan A, Kern P, Schultheis B, Häusler G, Rezniczek GA, Tempfer CB. Radiogenic angiosarcoma of the breast: case report and systematic review of the literature. BMC Cancer. 2018;18(1):463. Published 2018 Apr 24. doi:10.1186/s12885-018-4369-7
Darre T, Djiwa T, N'Timon B, Simgban P, Tchaou M, Napo-Koura G. Breast Primary Angiosarcoma: A Clinicopathologic and Imaging Study of a Series Cases. Breast Cancer (Auckl). 2022;16:11782234221086726. Published 2022 Mar 29. doi:10.1177/11782234221086726
Fraga-Guedes C, André S, Mastropasqua MG, et al. Angiosarcoma and atypical vascular lesions of the breast: diagnostic and prognostic role of MYC gene amplification and protein expression. Breast Cancer Res Treat. 2015;151(1):131-140. doi:10.1007/s10549-015-3379-2
Esposito E, Avino F, di Giacomo R, et al. Angiosarcoma of the breast, the unknown-a review of the current literature. Transl Cancer Res. 2019;8(Suppl 5):S510-S517. doi:10.21037/tcr.2019.07.38
Downloads
Published
Issue
Section
License
Copyright (c) 2025 Marina Balbino, Manuela Montatore, Federica Masino, Daniela Erriquez, Francesca Anna Carpagnano, Giuseppe Guglielmi
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Transfer of Copyright and Permission to Reproduce Parts of Published Papers.
Authors retain the copyright for their published work. No formal permission will be required to reproduce parts (tables or illustrations) of published papers, provided the source is quoted appropriately and reproduction has no commercial intent. Reproductions with commercial intent will require written permission and payment of royalties.
How to Cite
